NEW! Informing Patients of Their BIA-ALCL Risk: A Single Institution's Experience Sunday, September 30 Sun, Sep 30 8:00-9:00 a.m.
The program will provide a brief overview of Breast Implant Associated Anaplastic Large Cell Lymphoma and an update on the statistics of the disease. We will then focus on the steps necessary for an institution or a private practice group to gain approval to contact patients, identify and send letters to those patients, and then provide appropriate care. Based on our organization's experience, the learner will be provided with anticipated changes in call volumes, new consultations, and operative interventions. A model for managing the logistical, legal, and financial implications will be discussed.
At the end of this activity, participants will be able to:
- Highlight the newest statistics on BIA-ALCL
- Recognize the logistical difficulties in identifying and notifying patients of their BIA-ALCL risk
- List possible practice alterations to accommodate patients at risk for BIA-ALCL
- Implement an effective system to manage patients at risk for BIA-ALCL patients within their own practice
Educational Grant Provided by: Platinum: Allergan Medical
Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.
Designation: The ASPS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.